# VIP infusion as a bronchodilator in severe asthma | PepVault

Source: https://pepvault.app/research/vip-morice-1986

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [VIP](https://pepvault.app/research#vip)

Clinical trial · people

# VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this small hospital study, VIP given into a vein opened the airways in severe asthma, but less than salbutamol did.

- **Kind:** Clinical trial
- **Studied in:** People
- **Published:** 1986
- **Journal:** Peptides

## What they tested

The team tested whether VIP given into a vein opens the airways in people with severe asthma, and how it compares with the standard asthma drug salbutamol.

## How the study was done

A small clinical trial made of two studies, each in a small group of hospital in-patients who were recovering from a severe asthma attack. VIP was given as an intravenous drip (into a vein) at 6 pmol/kg/min and compared with salbutamol at 5 mcg/min, and VIP was also tested after pretreatment with nebulized ipratropium bromide, another airway drug.

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

After 30 minutes of the VIP drip, peak expiratory flow rate (PEFR, how fast a person can blow air out) rose by 26 +/- 9 l/min, a significant change (p less than 0.01). Salbutamol produced a rise of 39 +/- 19 l/min. When patients first had ipratropium bromide, VIP still raised peak flow by 25 l/min (p less than 0.02). The authors concluded that VIP widens the airways in severe asthma but less than standard medicine, and that reflex mechanisms are unlikely to explain its effect.

## What it doesn’t show

The groups were small and the effect was measured over a short drip. It tested only intravenous VIP in hospital patients recovering from an attack, so it says nothing about other routes, longer use or milder asthma.

## The paper

Morice and Sever Vasoactive intestinal peptide as a bronchodilator in severe asthma. Peptides. 1986.

- [PubMed (PMID 3529052)](https://pubmed.ncbi.nlm.nih.gov/3529052/)
- [The paper (DOI 10.1016/0196-9781(86)90202-0)](https://doi.org/10.1016/0196-9781%2886%2990202-0)

## The compound

- [VIP: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

## With this study

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Studies

- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025)
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [BPC-157 vs VIP](https://pepvault.app/peptides/compare/bpc-157-vs-vip)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on VIP

- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025) Randomized trial · people · 2025
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005) Clinical trial · people · 2005
- [VIP: tear levels rose after laser eye surgery, peaking at 1 week](https://pepvault.app/research/vip-kang-2023) Observational study · people · 2023
- [Every study on VIP](https://pepvault.app/research#vip)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### VIP

- [VIP: the full reference](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)

### Studies

- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025)
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005)
- [All 4 studies](https://pepvault.app/research#vip)

### Compared with

- [BPC-157 vs VIP](https://pepvault.app/peptides/compare/bpc-157-vs-vip)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking VIP? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on VIP](https://pepvault.app/research#vip)

## The library

- [VIP](https://pepvault.app/peptides/vip)
- [VIP dose guide](https://pepvault.app/lab/dosage/vip)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
